Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis. Xie Cherng VX, Har C, Roper H, Kornbluh AB, Kahn I Paediatr Drugs. 2026 Sep 21. PMID: 42768184. Abstract CommentRecommendBookmarkWatch
